Point72 Asset Management, L.P.
Position in VKTX — Viking Therapeutics, Inc.
CIK 1603466
STAMFORD, CT
Position in VKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,463,745
+$18,463,745 QoQ
Shares Held
473,308
Ownership
0.406%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#34
of 435 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Derivatives in VKTX
reported options exposure · as of Jun 30, 2026CallValue
$986,953
CallShares
25,300
PutValue
$390,100
PutShares
10,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. VKTX ranks #37 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in VKTX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,463,745 | 473,308 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $390,100 | 10,000 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $986,953 | 25,300 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $618,260 | 19,000 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $242,742 | 6,900 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $11,028,648 | 313,492 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $1,058,145 | 39,930 | Shares | Defined | 2025-08-14 | |
| 2024-03-31 | $10,987,180 | 133,990 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $4,927,142 | 303,957 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,995,000 | 300,000 | Call | Defined | 2023-05-15 | |
| 2023-03-31 | $18,204,027 | 1,093,335 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,392,640 | 1,105,600 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||